>
Switch to:

Creative Medical Technology Holdings Quick Ratio

: 0.11 (As of Jun. 2021)
View and export this data going back to 2009. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Creative Medical Technology Holdings's quick ratio for the quarter that ended in Jun. 2021 was 0.11.

Creative Medical Technology Holdings has a quick ratio of 0.11. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Creative Medical Technology Holdings's Quick Ratio or its related term are showing as below:

OTCPK:CELZ' s Quick Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 4
Current: 0.11

0.01
4

During the past 13 years, Creative Medical Technology Holdings's highest Quick Ratio was 4.00. The lowest was 0.01. And the median was 0.02.

OTCPK:CELZ's Quick Ratio is ranked lower than
99.99% of the 316 Companies
in the Biotechnology industry.

( Industry Median: 4.09 vs. OTCPK:CELZ: 0.11 )

Creative Medical Technology Holdings Quick Ratio Historical Data

The historical data trend for Creative Medical Technology Holdings's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Quick Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.01 0.07 0.01 -

Creative Medical Technology Holdings Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Quick Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - 0.08 0.11

Competitive Comparison

For the Biotechnology subindustry, Creative Medical Technology Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Creative Medical Technology Holdings Quick Ratio Distribution

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Quick Ratio falls into.



Creative Medical Technology Holdings Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Creative Medical Technology Holdings's Quick Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Quick Ratio (A: Dec. 2020 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.098-0)/40.521
=0.00

Creative Medical Technology Holdings's Quick Ratio for the quarter that ended in Jun. 2021 is calculated as

Quick Ratio (Q: Jun. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.159-0)/1.447
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Medical Technology Holdings  (OTCPK:CELZ) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Creative Medical Technology Holdings Quick Ratio Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings Business Description

Creative Medical Technology Holdings logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Ichim Thomas director 2027 E. CEDAR ST. TEMPE AZ 85281

Creative Medical Technology Holdings Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)